Related Articles
Efficacy and safety of TE/TEC/intensive paclitaxel neoadjuvant chemotherapy for the treatment of breast cancer
Circulating HER‑2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer
Efficacy analysis of trastuzumab, carboplatin and docetaxel in HER‑2‑positive breast cancer patients
Relationship between the signal ratios of HER-2/CEP17 and c-MYC/CEP17 and the pathological response of neoadjuvant therapy using docetaxel and trastuzumab in breast cancer
Expression of ERβ gene in breast carcinoma and the relevance in neoadjuvant therapy